Home delivery vs. clinics: new study tests easier way to get HIV prevention pills
NCT ID NCT06176859
Summary
This study is testing whether delivering HIV prevention medication (PrEP) directly to people in their communities is more effective than requiring them to visit clinics. It involves 2,500 young women and men in South Africa who are at high risk for HIV. The goal is to see if this easier, home-based approach helps more people start and continue using PrEP to stay HIV-negative.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Human Sciences Research Council
Durban, KwaZulu-Natal, South Africa
Conditions
Explore the condition pages connected to this study.